Todos Presentation from Nov 4 at NAI 500 GCFF which focused on connecting Chinese Investors to North American companies

https://www.youtube.com/watch?v=UliRr3-xDsQ&a...500andGCFF

Notes:
good Q/A on this presentation.
expect to be in phase 2/3 trial shortly
will focus on moderate after hospitalized. beyond that potential for pediatric and long covid and common cold.
interim data expected by end of year, potentially Nov 30.
Provista best month ever in October.
Videss launch Summer 2022.
Lympro data very soon
A number of partnership discussions ongoing ahead of P2 data
No need to raise capital today. Will raise capital at Nasdaq. Focus is on this data set, then Nasdaq.
quantitative EUA for Cpass soon